Author:
Zemni Imen,Gara Amel,Bennasrallah Cyrine,Ezzar Salma,Kacem Meriem,Chokri Roua,Maatouk Amani,Abroug Hela,Dhouib Wafa,Fredj Manel Ben,Bouanene Ines,Belguith Asma Sriha
Abstract
Abstract
Background
It has become increasingly clear that SARS-CoV-2 infection can lead to persistent physical and mental health problems lasting weeks or months, requiring prolonged periods of clinical care and increasing the burden on the healthcare system. This phenomenon, known as post COVID-19 syndrome (PCS), is a relatively new condition, its incidence is still unclear and differs between studies.
Objectives
In this cohort study, we aimed to estimate the incidence of PCS and to identify its risk factors in the Tunisian population.
Methods
This is a prospective cohort study that enrolled patients diagnosed with COVID-19 from the triage unit of the University Hospital of Monastir, Tunisia. between April 2021 and June 2022. Patients were contacted by phone for a follow-up evaluation of PCS 12- weeks after the diagnosis date.
Results
A total of 1451 individuals diagnosed with COVID-19 during the study period, responded to the follow-up evaluation after 3 months. The incidence of PCS was found to be 44.03% (95% CI [41.47; 46.58]), with fatigue being the most common symptom (21.5%), followed by cognitive impairment (10.3%), including memory loss and difficulty concentrating. Multivariate analysis revealed that the main associated factors to PCS were female gender (RR = 1.54; CI95% [1.30 - 1.82]), pre-existing comorbidities (RR = 1.30; CI95% [1.10 - 1.52]), duration of acute COVID-19 illness (days) (RR = 1.02; CI95% [1.01 - 1.03]), hospitalization (RR = 1.27; CI95% [1.05 - 1.53]), number of COVID-19 episodes (RR = 1.46; CI 95% [1.28 - 1.67]) and patients having receive two or more doses of vaccine prior to COVID-19 infection (RR = 0.82; CI95% [0.70 - 0.96]).
Conclusion
Our study allowed to estimate the incidence and identify risk factors of PCS. Recognizing these factors could help to better understand the underlying mechanisms and guide interventions for prevention and management of this condition.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Bonotti M, Zech ST. The Human, Economic, Social, and Political Costs of COVID-19. Recover Civ Dur COVID-19. 2021. p. 1–36.
2. Tae C, Amanda KM, Ann P, Megan HM, Arun V. Long COVID: Long-Term Effects of COVID-19. 2022. Internet, cited on 26 august 2023, Available on: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/covid-long-haulers-long-term-effects-of-covid19.
3. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.
4. Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLoS One. 2021;16(7):e0254523.
5. National Institute for Health and Care Excellence Guideline. OVID-19 rapid guideline: managing the long-term effects of COVID-19. London: NICE; 2020.